GE HealthCare Imaging CEO has 558 shares withheld

GE HealthCare Technologies Inc. officer Roland Rott, CEO of Imaging, reported a routine tax-related share withholding.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. officer Roland Rott, CEO of Imaging, reported a routine tax-related share withholding. On February 1, 2026, 558 shares of common stock were withheld at $78.97 per share to cover tax obligations from vesting restricted stock units. After this transaction, Rott directly owned 28,564 shares of GE HealthCare common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 558 shares

Exercise Price or Tax Liability 1 txn

Insider Rott Roland

Role CEO, Imaging

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	558	$78.97	$44K

Holdings After Transaction: Common Stock, par value $0.01 per share — 28,564 shares (Direct)

Footnotes (1)

1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GEHC executive Roland Rott report?

Roland Rott reported a tax-related share withholding, not an open-market sale. On February 1, 2026, 558 GE HealthCare common shares were withheld at $78.97 each to satisfy tax obligations tied to vesting restricted stock units.

How many GEHC shares were withheld for taxes in Roland Rott's Form 4?

The Form 4 shows 558 GE HealthCare common shares withheld. These shares were used to cover tax withholding obligations that arose when Rott’s restricted stock units vested, according to the filing’s explanatory footnote.

What is Roland Rott's remaining GEHC share ownership after the transaction?

After the February 1, 2026 transaction, Roland Rott directly owned 28,564 GE HealthCare common shares. This figure reflects his beneficial ownership following the 558-share tax withholding related to restricted stock unit vesting.

Was Roland Rott's GEHC transaction an open-market sale?

No, the transaction was not an open-market sale. The filing explains that 558 GE HealthCare shares were withheld specifically to satisfy tax withholding obligations associated with the vesting of restricted stock units, a common administrative process.

What role does Roland Rott hold at GE HealthCare Technologies Inc.?

Roland Rott serves as an officer of GE HealthCare Technologies Inc. with the title “CEO, Imaging.” His Form 4 filing reports changes in his beneficial ownership of the company’s common stock related to restricted stock unit vesting and tax withholding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 06:56 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rott Roland

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Imaging

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/01/2026		F		558(1)	D	$78.97	28,564	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.